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Summary
We describe the solution structures of two- and three-
domain constructs of the sensor histidine kinase PrrB
from Mycobacterium tuberculosis, which allow us to
locate the HAMP linker relative to the ATP binding
and dimerization domains. We show that the three-
domain construct is active both for autophosphoryla-
tion and for phosphotransfer to the cognate response
regulator, PrrA. We also describe the high-resolution
crystal structure of the catalytic domain alone, and
we show that, in solution, it binds ATP. The conforma-
tional flexibility of this domain is discussed and re-
lated to other structural information.
Introduction
Bacterial response to environmental conditions is regu-
lated by complex networks of interacting proteins, with
the most pathways being controlled by proteins belong-
ing to the so-called ‘‘two-component systems’’ (TCS)
(Parkinson, 1993). These systems are implicated in
a large variety of adapative responses, such as chemo-
taxis (Bilwes et al., 2003), regulation of osmolarity (In-
ouye et al., 2003), sporulation (Burbulys et al., 1991),
and redox potential (Oh and Kaplan, 2000). In many
pathogenic bacteria, TCSs can control sets of virulence
genes (Dziejman and Mekalanos, 1995) and are central
elements for the production of virulence factors (Ewann
et al., 2004). These signaling systems involve a sensor
histidine kinase (HK) and a response regulator (RR),
which, upon activation of the HK, communicate through
phosphotransfer from ATP to a histidine in the HK, fol-
lowed by phosphotransfer to an aspartic acid residue
in the cognate RR. The bacterial TCS regulatory mecha-
nism is thus distinct from the signaling systems present
in mammalians cells, and the inhibition of HKs can be
a potential target for drug discovery (Matsushita and
Janda, 2002).
Biochemical and mutagenesis studies have shown
that for the HKs, the kinase core domain catalyzes
ATP transautophosphorylation, in which one subunit of
the dimer phosphorylates the specific histidine residue
in the other subunit. The resultant phosphoimidazole
acts as a donor of the phosphoryl group to an aspartic
acid side chain of the RR. The RR is typically a DNA bind-
ing protein that, when activated by phosphorylation,
*Correspondence: tucker@embl-hamburg.deacts as a transcriptional regulator and can turn sets of
genes on or off. HKs display rather low overall sequence
homologies, because their N-terminal sensor domains
differ greatly. This reflects the wide variety of molecules,
and signals, that they sense. The characteristic feature
of the HK family is the kinase core, which consists of
independent dimerization and ATP binding (ATPase)
domains. The ATPase domain of the catalytic core is
characterized by five conserved amino acids motifs, four
of which (N, G1, F, and G2 boxes) form the nucleotide
binding pocket, (Robinson et al., 2000) and a recently
defined G3 box (Dutta and Inouye, 2000). The dimeriza-
tion domain contains the H box with the conserved his-
tidine residue that is the site of phosphorylation. This
domain is usually adjacent to the catalytic domain, but
it can be, as is the case for CheA, in the N-terminal part
of the protein and therefore separated from the ATPase
domain.
Genomic analysis indicates that Mycobacterium tu-
berculosis encodes 11 complete TCSs and 7 orphan re-
sponse regulator and sensor kinase proteins, compared
with around 30 such systems in Escherischia coli. Only
four of these genes, namely, SenX3-RegX3 (open read-
ing frame numbers in the sequenced H37Rv strain,
Rv0491 and Rv0490), PrrA-PrrB (Rv0903c-Rv0902c),
MprA-MprB (Rv0981-Rv0982), and MtrA-MtrB (Rv3246c-
Rv3245c), and two orphan proteins, Rv1626 and
Rv3220c, are conserved in all mycobacterial species
(Tyagi and Sharma, 2004) and may, therefore, be as-
sumed to play fundamental roles in the biology of myco-
bacteria.
The function of, and signals sensed by, TCS proteins
are often poorly understood, and only a few of them
have been partially characterized (Betts et al., 2002;
Sherman et al., 2001; Rodriguez et al., 2002; Zhart and
Deretic, 2001). In particular, the PrrA-PrrB TCS was
found to be implicated in the early intracellular multipli-
cation of M. tuberculosis (Ewann et al., 2002). The
cDNAs corresponding to cotranscripts from the PrrA-
PrrB locus have been recovered from M. tuberculosis
cultured in human blood monocyte-derived macro-
phages, but not from cells cultured in standard labora-
tory medium, indicating that the genes are transcribed
in response to one or more host cell-specific interac-
tions (Graham and Clark-Curtiss, 1999). Thus, this TCS
system, which is apparently important for survival within
macrophages, can be seen as a potential target for the
development of drugs.
PrrB is predicted to consist of 446 amino acids, and a
transmembrane segment divides the protein into a C-ter-
minal intracellular region and an N-terminal extracellular
region. Sequence analysis (e.g., PFAM; [Bateman et al.,
2004]) suggests that the C-terminal part of PrrB includes
a HAMP linker (residues 151–219), a histidine kinase
A domain (the dimerization/phosphoacceptor domain
containing residues 230–296), and a histidine kinase
ATPase domain (the catalytic domain containing resi-
dues 338–445). These regions are refered to below as
the H, D, and C domains, respectively. Present knowl-
edge about the HAMP linker is very limited compared
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HAMP linker is postulated to consist of two short amphi-
phatic a helices joined by an unstructured connector,
and computer modeling suggests that the a helices
may be in a coiled-coil conformation (Singh et al.,
1998). Recent studies on hybrid sensor kinases confirm
that the HAMP linker is an active participant in signal
transduction, and that it receives a signal related to li-
gand binding from the sensory module and conveys
that signal to the output module; however, the way in
which this process occurs remains unknown (Appleman
et al., 2003).
In this paper, we present the solution structures of
PrrBHDC and PrrBDC and the high-resolution crystal
structure of PrrBC, and we show that PrrBHDC is consti-
tuitively active.
Results and Discussion
PrrBHDC Is Active
The RR PrrA and the HK PrrB are located next to each
other on the MtB genome. Genomic colocalization of
cognate RRs and HKs is common in most bacteria. It
has previously been shown that PrrA and PrrB are coex-
pressed during phagocytosis in macrophages (Graham
and Clark-Curtiss 1999), indicating that PrrA and PrrB
are cognate RR and HK, respectively. To test whether
the truncated forms of PrrB, both of which are dimeric
in solution, are active, a self/transphosphorylation ex-
periment was performed with the cognate RR, PrrA.
The phosphorylation assays of PrrBHDC and PrrBDC
were performed by addition of [g -32P]ATP in the pres-
ence of Mg2+.
PrrBHDCwas readily self-phosphorylated in the given
conditions (see Experimental Procedures). Transfer of
the radioactive-labeled phosphoryl group from PrrBHDC
was observed immediately after addition of ATP. The
PrrBHDC constructs maintained transphosphorylation
for the next 10 min (Figure 1). The transphosphorylation
between the cognate components in the TCSs is often
highly specific. The phosphotransfer between PrrBHDC
and PdtaR (a noncognate RR) and PrrA and PdtaS (a
noncognate HK) does not show any transphosphoryla-
tion (Morth et al., 2005). This shows that PrrBHDC (as
well as PrrA) is active in the given conditions and indi-
cates that the truncated form of PrrB has kept its spec-
ificity to PrrA. Although we performed the assay with
PrrBDC as well (data not shown), both PrrA and PrrBDC
have similar molecular weights (25.4 and 26.0 kDa, re-
spectively) and the bands are not resolved, thus not
allowing us to show unambiguously specific phospho-
transfer. Nevertheless, we believe that in vitro only the
dimerization and ATP binding domains are necessary
for phosphotransfer to occur, although the rates of
phosphotransfer are likely to be different for the full-
length protein and the deletion mutants.
Although we can show activity and specificity for
phosphotransfer, we cannot estimate either the stoichi-
ometry or the efficiency of phosphotransfer from these
assays. This is because the lability of the phosphoami-
date bond in particular, noting that the gels were dried
before imaging, precludes any quantification. The effi-
ciency would, in any event, be affected by the absence
of the sensor domain. Since there is an excess of thesubstrate, ATP, we expected to observe an increased
amount of phosphorylated RR over time, and, indeed,
in similar assays on the PdtaR/PdtaS pair (Morth et al.,
2005), we do observe such an increase; however, since
the RR:HK molar ratio in the experiment is close to unity,
and bearing in mind the limitations of the assay men-
tioned above, this increase might not be detectable.
PrrBHDC Is Dimeric in Solution and Similar in Overall
Structure to CheA
The small-angle X-ray scattering (SAXS) curves for
PrrBHDCand PrrBDCare shown in Figure 2. The estimated
molecular weights of the solutes (55 6 4 kDa and 46 6
4 kDa, respectively) are consistent with a dimer, which
also agrees with the results from size-exclusion chroma-
tography. This is further corroborated by the excluded,
or Porod, volumes of the hydrated particle in solution
([110 6 7] 3 103 A˚3 and [81 6 5] 3 103 A˚3 for PrrBHDC
and PrrBDC, respectively). For globular proteins, the
hydrated volume in A˚3 should be about twice the molec-
ular mass in Da (see Experimental Procedures). The ex-
perimental radii of gyration and maximum sizes (34.5 6
0.5 A˚ and 120 6 10 A˚, respectively, for PrrBHDC, and
29.5 6 0.4 A˚ and 110 6 10 A˚, respectively, for PrrBDC)
point to a rather anisometric structure and indicate that
the N-terminal loops occupy the periphery of the particle.
The low-resolution shapes of PrrBHDC and PrrBDC recon-
structed ab initio fit the experimental data with c = 1.1
and 0.86, respectively (Figures 2 and 3A–3D). No 2-fold
restraints were placed on the ab initio models, which,
therefore, confirm the assumption of 2-fold symmetry.
The overall size of PrrBHDC is about 4 3 8 3 12 nm3,
and its comparison with the model of PrrBDC in Figure 3
suggests that the HAMP linker, missing in the latter con-
struct, occupies the upper part of the structure (compare
Figures 3A and 3B).
To obtain a more detailed model of PrrBHDC in solu-
tion, its structure was modeled by using atomic
Figure 1. In Vitro Transphosphorylation from PrrBHDC to PrrA
Purified PrrBHDC and PrrBDC were incubated in the presence of
[g-32P]ATP and the divalent cation Mg2+ for autophosphorylation,
and then PrrA was added for phosphotransfer to occur. The trans-
phosphorylation reaction was monitored after 10 min (lane 1). The
image on the left is of the Coomassie-stained gel, and that on the
right is of the phosphoimager image. The positions of PrrBHDC and
PrrA are marked. Lane 2 contains molecular weight markers only vis-
ible on the Coomassie-stained image.
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277coordinates of the dimerization and ATP binding do-
mains. A tentative dimeric model was derived from the
CheA dimerization domain (Bilwes et al., 1999) and the
X-ray structure of PrrBC (displayed in Figure 4A). This
model, however, yielded rather poor fits to the experi-
mental scattering curves (Figure 2), not only from
PrrBHDC (c = 2.9), but also from PrrBDC (c = 3.2). While
the latter discrepancy could have been explained be-
cause the N terminus is missing in the tentative model,
the former discrepancy suggests, rather, that there are
different positions of the ATP binding domains relative
to the preliminary model (compare Figures 3E and 3F).
The model was refined as described in the Experimental
Procedures by adding the missing loops as chains of
dummy residues and adjusting the position of the ATP
binding domain while retaining the P2 symmetry and
the dimerization interface. The experimental data from
PrrBHDC and PrrBDC were fitted simultaneously to yield
the discrepancy of c = 1.31 and c = 1.20, respectively.
Several independent simulated annealing runs gave re-
producible results with virtually identical positions of
the ATP binding domains and the N terminus (HAMP
linker) occupying the upper part of the molecule (Fig-
ure 3E). The overall shape of the final model and the lo-
cation of the N terminus are also consistent with the low-
resolution ab initio models constructed directly from the
scattering data without any a priori information about
the protein structure (see the superpositions in Figures
3A–3D). Thus, the SAXS-based model of PrrBHDC fits si-
multaneously the experimental scattering from PrrBHDC
and from PrrBDC (which is devoid of the HAMP linker). It
Figure 2. Experimental SAXS Data from PrrBHDC, 1, and PrrBDC, 2,
and the Scattering Curves Calculated from the Models Described
in the Text
Dots with error bars show the experimental curves. Red lines show
the scattering curves from ab initio models, green lines show the
computed scattering from the tentative dimeric model, and blue
lines show the scattering from the final refined model including the
missing loops. The logarithm of the intensity is displayed as a func-
tion of momentum transfer s = 4p sin(q)/l, where 2q is the scattering
angle and l = 1.5 A˚ is the X-ray wavelength.shows that the ATP binding domain approaches the he-
lices of the dimerization domain more closely than in the
initial model and therefore more closely than the dimer-
ization and ATP binding domains in CheA upon which
the initial model was based. This would be required for
phosphotransfer from the ATP binding domain to the
catalytic histidine in the dimerization domain. The
HAMP linker, modeled as a flexible loop of dummy res-
idues, occupies the part of the molecule above the cat-
alytic domain, but this model only represents the ap-
proximate configuration of the missing parts of the
structure and does not exclude a large degree of flexibil-
ity for the HAMP linker. In all independent simulated an-
nealing models, the N terminus is at the extremity of the
model, as would be required for linkage to the mem-
brane anchor.
The High-Resolution Crystal Structure of PrrBC
Indicates Inability to Bind ATP
Extensive attempts to crystallize the full-length PrrB or
the multidomain constructs PrrBHDC and PrrBDC from
Mycobacterium tuberculosis have so far been unsuc-
cessful, although the polypeptides were soluble. Of the
single-domain constructs, we have only been able to
obtain diffracting crystals of PrrBC. The polypeptides
without the ATP binding domain present were either
completely insoluble or not expressed at all, suggesting
that these properties are due to the lack of the ATP bind-
ing domain.
The crystal structure of PrrBC was solved by single-
wavelength anomalous diffraction (SAD) with a complete
data set collected on a single bromide-derivatized crys-
tal. The final, native structure was refined at 1.9A˚ resolu-
tion by using REFMAC5 (Murshudov et al., 1997) with
reasonable stereochemistry (Table 1).
Three identical monomers (which superimpose with
a maximum rmsd of 0.3 A˚ with all atoms used for the
superposition), which are not related by local proper
rotational symmetry, occupy the asymmetric unit. The
structure of one molecule, illustrated in Figure 4A, con-
sists of a single domain, with 150 residues, that folds
into a two-layer a/b sandwich with a mixed five-stranded
b sheet on one side (from left to right: b2b4b5b6b7) and
three a helices (a1, a2, and a3) on the other.
The three-dimensional structures of the C domain of
the related proteins, CheA (Bilwes et al., 2001), PhoQ
(Marina et al., 2001), EnvZ (Tanaka et al., 1998), and
NRII (NtrB; [Song et al., 2004]), have been previously
reported. These proteins are involved in chemotaxis, vir-
ulence, porin gene regulation, and nitrogen regulation,
respectively. The structure of PrrBC is compared with
crystal structures of these catalytic ATP binding do-
mains in Figure 4. An alignment of the amino acid
sequences based on the superimposition of structural
elements is shown in Figure 5. The rms deviations based
on 137 Ca atoms used were 1.76, 1.98, 1.78, and 2.15 A˚
when PrrBC was superimposed with PhoQ, NRII/NtrB,
EnvZ, and CheA, respectively. The largest differences
are observed in the case of NRII/NtrB, which also pos-
sesses two additional b strands that form a b hairpin in-
serted between strands b4 and b5 and CheA, which has
two additional a helices—one inserted between b4 and
a2 and the second in front of the ATP lid (see below).
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278Figure 3. Models from the Analysis of Small
Angle Scattering Data
(A and B) Ab initio models of (A) PrrBHDC and
(B) PrrBDC displayed as semitransparent
beads. The models are superimposed with
one of the final refined models of PrrBHDC
(dimerization domains are diaplayed in red,
catalytic domains are displayed in gray, and
the HAMP linker is displayed in blue).
(C and D) Views rotated counterclockwise by
90º around the vertical axis are shown.
(E and F) The superposition of three indepen-
dently refined models of PrrBHDC displayed
as blue, green, and magenta Ca traces is
shown in (E), and the initial tentative model
is shown in red in (F). The dimerization and
ATP binding domains and the HAMP linker
are indicated.Consequently, more detailed structural comparisons
are made only with the PhoQ structure.
The ATP lid, which covers the ATP binding site, is not
visible in our model of PrrBC (Figure 4A). When nucleo-
tide is absent and when there is no interaction with other
domains, the ATP lid is highly likely to be mobile, espe-
cially in view of the glycines in the G2 box. This situation
is seen in the NRII/NtrB (Figure 4C) and EnvZ (Figure 4D)
structures, where the lid is disordered. By comparing
the apo CheA domain, where the lid is visible (Bilwes
et al., 1999), with the ATPNP bound PhoQ domain
(Figure 4B), it was suggested that the lid may undergo
a conformational change, resulting in a partial closure,
in going from the apo to the ATP/ADP bound forms (Ma-
rina et al., 2001). However, a study of the ATP binding
(P4) domain of Thermotoga maritima CheA in complex
with ADP and three ATP analogs shows that there is
conformational variability of the ATP lid even when nu-
cleotide is bound (Bilwes et al., 2001). Only in one of
these structures (Figure 4E) is the lid totally defined, sug-
gesting that there might be an induced fit between the
ATP binding domain and the histidine-containing P1 do-
main. (Bilwes et al., 2001) Extensive attempts to obtain
crystals with nonhydrolyzable ATP analogs by cocrys-
tallization as well as soaking experiments were made;however, no additional density was observed in the an-
ticipated binding site. PrrBC shows high structural and
sequence similarity to the binding site of the PhoQ
ATP binding domain. Eight of the 12 residues (marked
as black arrows in Figure 5) around the ATP binding
site in PhoQ are identical to residues forming the puta-
tive binding pocket of PrrBC. Three of them are abso-
lutely conserved amongst histidine kinase ATP binding
domains, namely, Asn353 from the N box as well as
Asp380 and Gly384 from the G1 box. The remaining
identical residues are Asp349, Lys356, Arg399,
Leu412, and Ala436. Assuming that the ATP binding
site is enclosed by a flexible lid between b5 and helix
a3, we modeled ADPNP and magnesium from the
PhoQ structure (Marina et al., 2001) into the putative nu-
cleotide binding site of PrrBC (Figure 6). It was immedi-
ately obvious that residues 395–398 and 410–413, which
form the beginning and end of the otherwise disordered
ATP lid, respectively, point into the binding site. The
model indicates that there would be clashes between
residues Leu410, Ser398, and Gly411 with the a-phos-
phate, b-phosphate, and sugar ring, respectively.
Figure 6A shows a surface representation of the CheA
structure containing an open ATP lid with ADPNP mod-
eled into the binding pocket, while Figure 6B shows the
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279Figure 4. Structural Comparison of Different Histidine Kinase Catalytic Domains
(A–E) Cartoons showing the helices (yellow) and the strands (blue) of PrrBC (this work—no nucleotide and disordered ATP lid), PhoQ (bound nu-
cleotide with closed, ordered ATP lid), NRII/NtrB (no nucleotide, disordered ATP lid), EnvZ (NMR structure, bound nucleotide and ordered open
ATP lid), and CheA (P4 domain with bound ATPCP/Mg2+ and ordered ATP lid) are shown in (A)–(E), respectively. The nucleotide (where observed)
is shown in a red stick representation. Where the ATP lid is not visible, the ends of the polypeptide chain adjacent to the disordered region are
colored red. (E) The two helical insertions in CheA are also colored red.CheA structure with bound ADPNP. For comparison,
Figure 6C shows ADPNP modeled into PrrBC by using
the CheA structure (Bilwes et al., 2001) as a template.
The geometry of nucleotide binding is slightly different
compared to that in the PhoQ structure, but the result
is the same, namely, unacceptable steric clashes. The
electron density of the residues involved is well defined;
thus, the potential hindrance for binding a nucleotide
molecule is real and not a misinterpretation of the elec-
tron density. In addition, helix a2 (shown in yellow in Fig-
ure 6) is shifted around 2A˚ toward the binding site, when
compared with the corresponding helix in CheA, and, as
a consequence, the ATP binding site is blocked by
His384, which would clash with g-phosphate of bound
ATP (Figure 6C). Presumably (see below), this helix can
undergo conformational changes in order to facilitate
nucleotide binding. We assume that the autoinhibited
conformation of a2 helix is determined by the crystal
packing. The molecules are packed in such a way that
the C-terminal part of one molecule points into the a2
helix of another.
We identified three Tris(hydroxymethyl)aminome-
thane (Tris) molecules from the buffer that were almostidentically bound to each independent protein molecule
(Figure 7), which, in turn, are associated with surface-ex-
posed Cys residues. The amino group and all of the hy-
droxyl groups of the Tris molecules are involved in the
intermolecular hydrogen bonding network. The amino
group and one of the hydroxyl groups hydrogen bond
to water, which, in turn, makes a hydrogen bond to
Cys334 of one protein molecule. The other two hydroxyl
groups hydrogen bond to Ser446 of the same molecule
and Tyr321 and Lys356 of a second molecule (Figure 7B).
These interactions are identical for two of the three inde-
pendent Tris molecules, whereas for the third one,
Lys356 is, instead, linked to a Tris hydroxyl group via
a water molecule. Importantly, Lys356 is a part of the
a2 helix, and, consequently, these interactions are
strong determinants of the crystal packing.
To investigate the importance of this crystal contact,
we mutated Cys334 to Gly. We have been unable to ob-
tain any crystals of this mutant, under any conditions,
and this fact implies that intermolecular contacts in the
original crystals are conditional on the presence of the
cysteine residue and the hydrogen bonding network in-
volving Tris.
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280Table 1. Data Collection and Refinement Statistics
Native Br Derivative
Data Collectiona
Beamline 5.0.1 ALS, Berkeley BW7A EMBL, Hamburg
Wavelength (A˚) 1.0 0.92
Space group P65 P65
Cell Parameters (A˚) a = b = 61.48, c = 211.33 a = b = 61.37, c = 210.47
Maximum resolution (A˚) 1.90 2.5
No. of unique reflections 32,808 15,389
Completeness (%) 97.7 (87.1) 99.9 (100)
Multiplicity 8.3 (8.0) 18.1 (18.0)
<I>/s<I> 31.5 (2.0) 30.0 (6.1)
Rsym (%)
b 7.5 (66.0) 4.8 (57.4)
Refinement
Resolution (A˚) 20–1.9
Rwork
c/Rfree
d (%) 18.6/23.5
Number of residues 462
Number of waters 206
Number of Tris molecules 3
Rmsd bonds (A˚) 0.02
Rmsd angles (º) 1.90
Ramachandran Plot
Most favored (%) 95.5
Additional allowed (%) 4.5
a Numbers given in brackets are from the last resolution shell.
b Rsym = ShklSiIi(hkl) 2 <I(hkl)>/ShklSiIi(hkl), where Ii is the intensity of the i
th reflection and <I> is the average intensity.
c Rwork = ShkljFoj 2 jFcj/ShkljFoj, where Fo is the observed structure factor and Fc the calculated.
d Rfree was calculated as for Rwork but on 5% of the reflections excluded from the refinement.In Solution, PrrBC Binds ATP
To confirm that the apparent structural hindrance to ATP
binding is an artifact of the crystal packing, we decided
to investigate the affinity of PrrBC for ATP by using a fluo-rescent analog of the nucleotide, MANT-ATP. The com-
plex formation was studied by the changes in MANT-
ATP fluorescence at the emission maximum of 445 nm.
Binding to the protein caused decreased intensity ofFigure 5. A Structure-Based Sequence
Alignment of the Histidine Kinase ATP Bind-
ing Domain
The sequences of the catalytic domains of
PrrB, PhoQ, NRII/NtrB, EnvZ, and CheA
were initially aligned with ClustalW (Higgins
et al., 1994) and then adjusted by hand ac-
cording to the secondary structure elements
observed in the NMR or crystal structures.
Identical or similar residues in all sequences
are highlighted in red and green, respectively.
Common a helices and b strands are shown
as yellow cylinders and blue arrows, respec-
tively. The additional secondary elements in
NRII/NtrB and CheA are shown as gray ar-
rows and orange cylinders, respectively.
The 12 residues around the ATP binding site
are indicated by black arrows.
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281Figure 6. Surface Representation Showing the Accessibility of the ATP Binding Site
(A–C) A surface representation of (A) CheA in the open conformation with an ATP molecule modeled into the active site, (B) CheA in the closed
conformation with bound ATP, and (C) the completely closed conformation observed in PrrBC. Helix a2 is indicated in yellow. The (A and C) mod-
eled and (B) observed nucleotides are shown in stick representation.the MANT-ATP nucleotide emission and followed a hy-
perbolic curve, corresponding to the saturation of a sin-
gle binding site (Figure 8). The dissociation constant of
the complex was measured to be Kd = 0.17 6 0.02 mM.
The binding studies were performed in the presence of
Tris buffer, and no inhibition effect was observed. The
corresponding dissociation constants for PhoQ/ATP
and CheA/ATP are, for comparison, 21 mM and 14 mM,
respectively; however, it should be pointed out that, in
the latter case, the ATP derivative TNP-ATP, which
acts as an inhibitor of phosphotransfer, has a much
higher affinity, with a Kd of less than 0.01 mM.
The observed decrease of the MANT-ATP intensity
upon binding to PrrBC suggests a polar surrounding of
the bound nucleotide and static quenching of its emis-
sion. The MANT-ATP fluorescence is known to be sensi-
tive to the local environment (Toshiaki, 1983), and the
ATP binding site in PrrBC consists mainly of hydrophilic
residues, which would be expected to cause the ob-
served decrease. Comparing the PhoQ nucleotide
structure with PrrBC shows that the residues surround-
ing the phosphate groups and the sugar ring in PrrBC
would be mainly charged. In addition, the adenine
base, despite its largely hydrophobic nature, forms wa-
ter-mediated hydrogen bonds with conserved Asp415
and Gly417 from the G1 box (Marina et al., 2001). Similar
polar contacts involving the adenine ring have been ob-
served in the case of the DNA gyrase B protein (Wigley
et al., 1991).Experimental Procedures
Cloning, Expression, and Purification
A full-length copy of the PrrB gene open reading frame (Rv0902c
from the H37Rv strain of Mycobaterium tuberculosis) was obtained
by PCR amplification from the genomic DNA as a template by using
the Herculase Hotstart DNA polymerase (Stratagene) with the
primers 50-CCATATGGCTAATATTCTGTCGCGGATCTTCGCCCGTA
CGCCCTCG-30 and 50-CCAAGCTTACCTCGTGGTACACCCTGGGC
CCGGGAAGGCGCA-30. The plasmids used for expression of the
constructs, PrrBHDC (residues 174–446, which contains HAMP
linker, dimerization/phosphotransfer, and ATP binding domains),
PrrBDC (residues 223–446, with dimerization/phosphotransfer and
ATP binding domains), PrrBH (residues 174–223, HAMP linker alone),
PrrBD (residues 223–291, dimerization domain alone), and PrrBC
(residues 297–446, the ATP binding domain alone), were amplified
by PCR from the plasmid containing the full-length copy of the
PrrB gene. The oligonucleotides flanking the gene of interest were
designed in a way to provide melting temperatures around 70ºC
with extensions encoding NcoI and XhoI restriction sites at the 50
and 30 ends, respectively. The forward primers inserted the GTA co-
don immediately after the start codon to preserve the reading frame
and were as follows: 50-CATGCCATGGTACGCCCGTTCAAGCA
GC-30 for PrrBHDC and PrrBH, 50-CATACCATGGTACGAACAAAGGA
GGCGCTTGC-30 for PrrBDC and PrrBD, and 50-CATACCATGGTAAC
CTCGGAC-30 for PrrBC. The reverse primer 50-ATGCTCGAGATT
AACTGGGTCCGGGAAGGCGC-30 was used to prepare all recombi-
nant fragments of PrrB containing the ATP binding domain, and 50-
GACCTCGAGATTATCGGTTCTGCTCGTTCC-30 and 50-ATGCTCGA
GATTAGGCCAACCGCTCCAGC-30 were used for PrrBH and PrrBD,
respectively.
All proteins were produced with N-terminal His6 tags by insert-
ing the PCR products into the pET-M11 vector (EMBL) restricted
with the same enzymes. Insertions were checked by sequencing.
Structure
282Figure 7. The Tns-Dependent Intermolecular
Interactions
(A) The three independent molecules in
green, yellow, and blue, showing the position
of the Tris molecules in ball-and-stick repre-
sentation.
(B and C) The differences in the hydrogen
bonded linkage involving the Tris molecule
and Cys334 between the yellow and green
and blue and green molecules are shown in
(B) and (C), respectively.Site-directed mutagenesis was performed by using the Quick-
Change system (Stratagene) in order to obtain the Cys(334)-Gly
mutant.
Full-length PrrB, PrrBHDC, PrrBDC, and PrrBC were expressed in
Escherichia coli strain Rosetta(DE3)pLysS cells treated with 1 mM
isopropyl-1-thio-b-D-galactopyranoside to induce expression of
the protein and were grown for 5 hr at 25ºC. The cells were then har-
vested by centrifugation and stored at 280ºC until required. Cells
(10 g) were thawed, resuspended in 40 ml lysis buffer A (50 mM
Tris-HCl, 200 mM NaCl, 5 mM betamercaptoethanol [pH 7.5]) with
Figure 8. Analysis of the MANT-ATP Binding to PrrBC
MANT-ATP (2.5 mM) was titrated with increasing concentrations of
PrrBC at 20ºC, in 20 mM Tris-HCl (pH 7.5) containing 5 mM MgCl2.
Changes of the MANT emission after excitation at 400 nm were mea-
sured. It was assumed that the maximal fluorescence represents
100% binding, and that the amount of the fluorescent probe bound
is proportional to the relative intensity. The derived curve is fitted by
a nonlinear regression for a single binding site, and the calculated Kd
value is 0.17 6 0.02 mM.addition of two protease cocktail inhibitor tablets (ROCHE), and
lysed by sonication. The debris was removed by centrifugation at
20,000 rpm, and the supernatants were filtered with a 0.22 mm filter
before loading onto a 5 ml Ni-HiTrap column equilibrated in buffer A.
The proteins were eluted with 15 ml buffer A containing 200 mM
imidazole. The fractions containing PrrB were pooled and diluted
to a final imidazole concentration of 50 mM. The protein was mixed
with TEV protease (EMBL) in a 1:20 ratio and left at 4ºC overnight in
order to cleave the His6 tag. The digested protein was applied again
to the Ni-Hitrap column equilibrated in buffer A containing 50 mM im-
idazole. The flowthrough fractions were collected, concentrated to
a final volume of 5 ml, and further purified on a HiLoad 26/60 Super-
dex200 column equilibrated in buffer B (20 mM Tris-HCl, 100 mM
NaCl, 2 mM DTT [pH 7.5]). The peak fractions were concentrated
with a centricon-10 kDa cutoff (VIVASPIN) to a concentration of
10 mg/ml, as measured by Bradford’s assay (Bradford, 1976).
PrrBHDC and PrrBDC appear as dimers by size-exclusion chroma-
tography, and PrrBC appears as a monomer. The full-length protein,
although soluble, runs as an oligomer, probably as a result of the
predicted membrane-spanning helices in the N-terminal region.
PrrBH didn’t show any expression, whereas PrrBD was only obtained
as insoluble material.
Crystallization
Crystallization of PrrBC was carried out at 19ºC by using the hanging
drop vapor diffusion method. The initial conditions (22% [w/v] PEG
2000DME, 64 mM calcium acetate, 100 mM Bis Tris Propane [pH
7.5]) were obtained from the MTB Structural Genomics Crystalliza-
tion Facility (www.doe-mbi.ucla.edu/TB). The best crystals were ob-
tained after 1 week by mixing protein solution in buffer B and reser-
voir buffer (17% [w/v] PEG 2000DME, 140 mM calcium acetate, 100
mM Bis Tris Propane [pH 8]) in a 1:1 (v/v) ratio. Heavy-atom deriva-
tization was achieved by soaking crystals in the reservoir solution
containing 1 M sodium bromide. After increasing the concentration
of PEG 2000DME to 25% (v/w), crystals were flash cooled at 100 K in
the cold nitrogen stream of an Oxford Cryosystems Cryostream.
Crystals belong to space group P65, with unit cell parameters
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metric unit and an estimated solvent content of 51%. Diffraction
data were collected at Beamline 5.0.1 of the Advanced Light Source
for the native crystals and at the X11 beamline of the EMBL Hamburg
for Br-derivatized crystals. Data were processed with DENZO,
scaled with SCALEPACK (Otwinowski and Minor, 1997), and con-
verted to structure amplitudes by using the program TRUNCATE
within the CCP4 program suite (CCP4, 1994). Table 1 shows data
collection and processing statistics.
Structure Determination
The protein crystal was treated with NaBr as described above, and
highly redundant X-ray derivative data were collected just to high
energy of the bromine absorption edge (Table 1). An interpretable
map and partial model were achieved by using the SAD protocol
of Auto-Rickshaw, an automated crystal structure determination
pipeline (Panjikar et al., 2005). Within the pipeline, heavy-atom posi-
tions were located by using the program SHELXD (Schneider and
Sheldrick, 2002). The 20 bromide sites were refined, and initial
phases were calculated with MLPHARE as implemented in the CCP4
program suite (CCP4, 1994). The program PROFESSS (CCP4, 1994)
was used to determine the noncrystallographic symmetry operators
from the heavy-atom positions. Density modification and averaging
were performed by using DM (Cowtan, 1994), and ESSENS was used
(Kleywegt and Jones, 1997) for building helices into the preliminary
experimental map.
40% of the model was correctly built in a first run of ARP/wARP
(Perrakis et al., 1997), despite a resolution of only 2.5 A˚. A more com-
plete model was assembled by using the model produced sequen-
tially with several runs of ARP/wARP interspersed with manual
model building with O (Jones et al., 1991). When the model became
85% complete, side chains were placed by using the program GUI-
SIDE, and their position was checked manually to ensure that the
side chains were in density. At this stage, refinement was com-
menced by using rigid-body, positional, and B factor refinement
protocols as implemented in CNS (Brunger et al., 1998). At this
stage, the R factor and Rfree of the model were 37.3% and 42.2%, re-
spectively. After initial refinement in CNS, the model was used as
a search model against the 1.9 A˚ resolution native data by using
the program MOLREP (Vagin and Teplyakov, 1997). The resultant
model was then used for automatic model rebuilding with ARP/
wARP. 84% of the structure was correctly built in 13 building cycles.
Further refinement was continued by using REFMAC5 (Murshudov
et al., 1997). The model was iteratively improved by a combination
of refinement and manual building with O (Jones et al., 1991). The fi-
nal stages of refinement were carried out by using a bulk solvent cor-
rection and anisotropic scaling as implemented in REFMAC and
without using NCS restraints. The refinement was monitored
throughout by using an Rfree calculated with 5% of the unique reflec-
tions.
In the final 1.9 A˚ model, 4 residues at the N terminus (Gly, Ala, Met,
Ala) introduced during the cloning procedure, together with Thr297
and Ser298 as well as the residues 399–409 of the flexible loop form-
ing the ATP –lid, are disordered. The model contains 206 modeled
water oxygens and 3 Tris molecules. Of the modeled residues, anal-
ysis of the main chain dihedral angles by PROCHECK (Laskowski
et al., 1993) shows 95.5% in the most favored regions and 4.5% in
the additionally allowed regions. None of the residues are in gener-
ously allowed or disallowed regions. The average atomic B factor for
all atoms is 35 A˚2.
Small-Angle X-Ray Scattering
The synchrotron radiation X-ray scattering data were collected on
the X33 camera (Koch and Bordas, 1983; Boulin et al., 1988) of
the EMBL (on the DORIS III storage ring at DESY). Solutions of
PrrBHDC were measured at protein concentrations of 2.5, 5.5, 7.5,
11.0, and 60 mg/ml by using a linear proportional gas detector (Ga-
briel and Dauvergne, 1982), at two sample-detector distances (2.4 m
and 1.2 m) and a wavelength of l = 1.5 A˚, covering ranges of momen-
tum transfer of 0.013 < s < 0.33 A˚21 and 0.03 < s < 0.6 A˚21 (Figure 2,
(1)). Solutions of PrrBDC were measured at protein concentrations of
3.0, 7.5, and 15.0 mg/ml at the sample-detector distance of 2.7 m
and the same wavelength, by using a MAR345 two-dimensional
image plate detector (see http://www.marresearch.com/ip.htm), inthe range of 0.12 < s < 4.5 nm21 (Figure 2, (2)). The larger error
bars for PrrBHDC are at the extreme edge of the scattering vector
range for the first detector position and contribute little to the fit
since the errors from the second detector position (which overlap
with the first) are much smaller. To check for radiation damage, for
the gas detector the data were collected in 15 successive 1 min
frames; for the image plate, two 2 min exposures were compared;
no radiation damage effects were observed. The data were aver-
aged after normalization to the intensity of the incident beam, cor-
rected for the detector response, and the scattering of the buffer
was subtracted. The difference data were extrapolated to zero sol-
ute concentration by following standard procedures. For the gas de-
tector, the curves measured in different angular intervals were
merged. All data manipulations were performed with the program
package PRIMUS (Konarev et al., 2003).
The maximum particle dimension, Dmax, was estimated by using
the orthogonal expansion program ORTOGNOM (Svergun, 1993).
The forward scattering, I(0), and the radius of gyration, Rg, were eval-
uated by using the Guinier approximation (Guinier, 1939), assuming
that at very small angles (s < 1.3/Rg) the intensity is represented as
I(s) = I(0) exp(-(sRg)
2/3). These parameters were also computed
from the entire scattering patterns by using the indirect transform
package GNOM (Svergun, 1992), which also provides the distance
distribution function, p(r), of the particle. The molecular masses
(MM) of the solutes were evaluated by comparison of the forward
scattering with that from reference solutions of bovine serum albu-
min (MM = 66 kDa). The excluded volume of the hydrated particle
(the Porod volume) was computed by using the equation (Porod,
1982):
V = 2p2Ið0Þ=ÐN
0
s2IexpðsÞds: (1)
Prior to this analysis, an appropriate constant was subtracted from
each data point to force the s24 decay of the intensity at higher an-
gles by following Porod’s law (Porod, 1982) for homogeneous parti-
cles. This ‘‘shape scattering’’ curve was further used to generate
low-resolution ab initio models of PrrBHDC and PrrBDC by using the
program DAMMIN (Svergun, 1999), which represents the protein
by an assembly of densely packed beads. Simulated annealing
was employed to build a compact, interconnected configuration of
beads inside a sphere with the diameter Dmax that fits the experi-
mental data Iexp(s) to minimize the discrepancy:
c2 =
1
N2 1
X
j

IexpðsjÞ2cIcalcðsjÞ
sðsjÞ
2
; (2)
where N is the number of experimental points, c is a scaling factor
and Icalc(s) and s(sj) are the calculated intensity and the experimental
error at the momentum transfer, sj, respectively.
The scattering from the putative model of PrrBDC built from the
atomic coordinates of the dimerization domain of CheA (residues
293–356) and of the ATP binding domain of PrrBC (residues 303–
446) was calculated with the program CRYSOL (Svergun et al.,
1995). Given the atomic coordinates, the program minimizes the dis-
crepancy in the fit to the experimental intensity by adjusting the ex-
cluded volume of the particle and the contrast of the hydration layer.
The refinement of the structure of the PrrBHDC dimer in solution was
performed based on the above-mentioned putative model. The
missing 59 N-terminal residues (HAMP linker) and the ATP lid (con-
taining amino acids 399–409) as well as the interdomain linker (res-
idues 115–122) were represented as interconnected chains com-
posed of dummy residues (Petoukhov et al., 2002). The putative
model was oriented to bring the 2-fold axis coincident with the z
axis, and the position of the dimerization domain was fixed to ensure
the proper dimerization interface. A simulated annealing protocol
implemented in the program BUNCH (Petoukhov and Svergun,
2005) was employed to find the optimal position and orientation of
the ATP binding domain and probable conformations of the loops
represented as dummy residues. In all computations, the configura-
tion of one monomer was modified, while its symmetry mate was
generated automatically. The scattering amplitudes of the domains
in the reference positions were calculated with CRYSOL, and the
amplitudes of the loops were calculated by using the form factor
of a dummy residue (Svergun et al., 2001; Petoukhov et al., 2002).
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domain and local modifications of the loops. The final model should
simultaneously fit the experimental scattering from PrrBHDC and
PrrBDC by the scattering computed from the full-length protein
and from the PrrBDC fragment, respectively, without steric clashes
and with native-like folds of the loops.
Fluorescent Measurements and ATP Binding
The fluorescent ATP analog N-methylanthraniloyl-ATP (MANT-ATP),
used in the binding experiments, was purchased from Molecular
Probes (www.probes.com). Steady-state fluorescence measure-
ments were carried out with a Fluoromax Spectrofluorimeter, equip-
ped with a thermostatically controlled cuvette holder. All binding ex-
periments were performed at 20ºC in 20 mM Tris-HCl (pH 7.5)
containing 5 mM MgCl2.
MANT-ATP was selectively excited at 400 nm, at which only the
dye absorbed, and the emission spectra were recorded between
405 and 505 nm. In order to minimize inner filter and self-absorption
effects, absorbance of the samples at the excitation wavelength
(lexc) was always maintained at less than 0.05. ATP association to
PrrBC was followed by the changes in MANT-ATP emission at
450 nm, at which 2.5 mM MANT-ATP was titrated with increased con-
centrations of the protein. All spectra were corrected for the inner fil-
ter effect and dilution. The dissociation constant (Kd) of the complex
and the maximum fluorescence change (DF) of the MANT-ATP deriv-
ative were calculated with the GraphPad Prism program (Motulsky,
1999). The data were analyzed by nonlinear regression and fitted to
a one-site binding hyperbola.
Phosphorylation Assay
Phosphorylation assays were performed with 87 ml PrrBHDC and
PrrBDC at concentrations of 0.2 g/ml. They were mixed with 3 ml
100 mCi [g-
32P]ATP and 10 ml 0.1 mM ATP (cold) in Buffer C (40 mM
Tris-HCl [pH 8.0], 40 mM KCl, 8 mM MgCl2, and 8% glycerol) and
were incubated for 5 min at 30ºC. The final concentrations of
PrrBHDC and PrrBDC were 5.4 and 6.5 mM, respectively. For phospho-
transfer assays, 4 ml of the cognate response regulator, PrrA
(Rv0903c at 6 mg/ml), was added (9.1 mM final concentration). Ali-
quots (20 ml) of the reaction were quenched after specific time inter-
vals (0, 2, 5, 10 min) by addition of sodium dodecyl sulfate SDS elec-
tophoresis loading buffer (NOVAGEN). After SDS-PAGE on a 12.5%
gel, the gel was stained with Coomassie blue. After drying, gels were
exposed for 1 hr to a phosphoimaging screen (Fuji FLA-2000) for
identification of radioactive bands.
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